Physician profile
Jon D Larson
NPI 1508884172
$234.50
in general payments reported to CMS, 2019-2025
11 companies · $67.25 in 2025
The $67.25 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.49 · 2022: $58.73 · 2023: $67.03 · 2025: $67.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $38.37 | 2021-2023 | Xospata |
| Phathom Pharmaceuticals, INC. | $36.24 | 2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $27.60 | 2021 | |
| Pfizer INC. | $25.83 | 2022-2023 | |
| Corium, LLC | $19.19 | 2022 | |
| Lundbeck LLC | $16.44 | 2025 | Rexulti |
| Seagen INC. | $15.87 | 2023 | Tukysa |
| Otsuka America Pharmaceutical, INC. | $14.57 | 2025 | Rexulti |
| Astrazeneca Pharmaceuticals Lp | $13.90 | 2022 | |
| Exact Sciences Corporation | $13.75 | 2023 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.